Jointown Pharmaceutical Group Co., Ltd

Shanghai Stock Exchange 600998.SS

Jointown Pharmaceutical Group Co., Ltd Gross Profit for the year ending December 31, 2023: USD 1.71 B

Jointown Pharmaceutical Group Co., Ltd Gross Profit is USD 1.71 B for the year ending December 31, 2023, a 7.52% change year over year. Gross profit is the difference between revenue and the cost of revenue, representing the profit earned from core business operations.

Jointown Pharmaceutical Group Co., Ltd Gross Profit for the year ending December 31, 2022 was USD 1.59 B, a 2.47% change year over year.
Jointown Pharmaceutical Group Co., Ltd Gross Profit for the year ending December 31, 2021 was USD 1.55 B, a 1.67% change year over year.
Jointown Pharmaceutical Group Co., Ltd Gross Profit for the year ending December 31, 2020 was USD 1.52 B, a 21.86% change year over year.
Jointown Pharmaceutical Group Co., Ltd Gross Profit for the year ending December 31, 2019 was USD 1.25 B, a 14.26% change year over year.

Key data

Date	Gross Profit	Operating Income	EBIT	EBITDA

Shanghai Stock Exchange: 600998.SS

Jointown Pharmaceutical Group Co., Ltd

CEO	Mr. Wei He
IPO Date	Nov. 2, 2010
Location	China
Headquarters	No. 8, Longyang Avenue
Employees	30,100
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies Retail & Wholesale

Description

Jointown Pharmaceutical Group Co., Ltd provides marketing, distribution, and logistics services for digital pharmaceutical businesses. It wholesales Chinese herbal medicines, Chinese patent medicines, chemical medicinal materials, chemical medicine preparations, antibiotic preparations, biochemical drugs, biological products, chemical raw materials, and medical toxic drugs. The company was founded in 1999 and is based in Wuhan, China.

Key trends

Past 5 years